Title Managing Director, Managing Director, Global Health Innovation Fund Company Merck Bio Max Kahn is a Managing Director of the Merck Global Health Innovation Fund (Merck GHI) and seeks opportunities in Technology Enabled Care, with a particular emphasis on solutions for Provider and Patient Engagement. Mr. Kahn currently serves as a member of the Board of Directors of Healthsense and PatientSafe Solutions. Mr. Kahn brings over twenty years of experience in health care and emerging company investing, business development, and strategy creation and implementation. Before Merck GHI, he was in the health care strategy & alliances group at Johnson & Johnson, responsible for their new business model strategies. Prior to J&J, Mr. Kahn worked in the health care and insurance practices at McKinsey & Co.and also as a health care services and health care information investment banker at Commonwealth Associates. Mr. Kahn holds an MBA from Columbia University and a BA from the University of Pennsylvania.